Although a large part of this increase in prostate cancer survival in the general population has been due to the increase in the number of diagnoses of tumors with a very good prognosis caused by the widespread use of the prostate-specific antigen (PSA) test, both studies concluded that the information about stage only is not enough to explain the differences in survival observed among countries. Here, KLK3 is linked to prostate carcinoma.